Abstract:BACKGROUND:Breast cancer negatively affects women's health worldwide. The tumour microenvironment plays a critical role in tumour initiation, proliferation, and metastasis. Cancer cells are traditionally grown in two-dimensional (2D) cultures as monolayers on a flat solid surface lacking cell-cell and cell-matrix interactions. These experimental conditions deviate from the clinical situation. Improved experimental systems that can mimic the in vivo situation are required to discover new therapies, particularly for anti-angiogenic agents that mainly target intercellular factors and play an essential role in treating some cancers.METHODS:Chitosan can be modified to construct three-dimensional (3D) tumour models. Here, we report an in vitro 3D tumour model using a hydroxyethyl chitosan/glycidyl methacrylate (HECS-GMA) hydrogel produced by a series of chitosan modifications. Parameters relating to cell morphology, viability, proliferation, and migration were analysed using breast cancer MCF-7 cells. In a xenograft model, secretion of angiogenesis-related growth factors and the anti-angiogenic efficacy of Endostar and Bevacizumab in cells grown in HECS-GMA hydrogels were assessed by immunohistochemistry.RESULTS:Hydroxyethyl chitosan/glycidyl methacrylate hydrogels had a highly porous microstructure, mechanical properties, swelling ratio, and morphology consistent with a 3D tumour model. Compared with a 2D monolayer culture, breast cancer MCF-7 cells residing in the HECS-GMA hydrogels grew as tumour-like clusters in a 3D formation. In a xenograft model, MCF-7 cells cultured in the HECS-GMA hydrogels had increased secretion of angiogenesis-related growth factors. Recombinant human endostatin (Endostar), but not Bevacizumab (Avastin), was an effective anti-angiogenic agent in HECS-GMA hydrogels.CONCLUSIONS:The HECS-GMA hydrogel provided a 3D tumour model that mimicked the in vivo cancer microenvironment and supported the growth of MCF7 cells better than traditional tissue culture plates. The HECS-GMA hydrogel may offer an improved platform to minimize the gap between traditional tissue culture plates and clinical applicability. In addition, the anti-angiogenic efficacy of drugs such as Endostar and Bevacizumab can be more comprehensively studied and assessed in HECS-GMA hydrogels.

Hydrogel Microenvironments for Cancer Spheroid Growth and Drug Screening.

Recent Advances in Three-Dimensional Multicellular Spheroid Culture and Future Development

High Quality Multicellular Tumor Spheroid Induction Platform Based on Anisotropic Magnetic Hydrogel.

Polyglycerol-Based Hydrogel as Versatile Support Matrix for 3D Multicellular Tumor Spheroid Formation

Three-Dimensional Microstructured Poly(vinyl Alcohol) Hydrogel Platform for the Controlled Formation of Multicellular Cell Spheroids

Mixed Hydrogel Bead-Based Tumor Spheroid Formation and Anticancer Drug Testing

Application of hydrogels for targeting cancer stem cells in cancer treatment

Multicellular Spheroids Formation and Recovery in Microfluidics-Generated Thermoresponsive Microgel Droplets

Biomacromolecular hydrogel scaffolds from microfluidics for cancer therapy: A review

Impact of hydrogel biophysical properties on tumor spheroid growth and drug response

Uniform sized cancer spheroids production using hydrogel-based droplet microfluidics: a review

Bioactive Microgels with Tunable Microenvironment as a 3D Platform to Guide the Complex Physiology of Hepatocellular Carcinoma Spheroids

In Situ Formation of Microgel Array Via Patterned Electrospun Nanofibers Promotes 3D Cell Culture and Drug Testing in a Microphysiological System.

Controlled Generation of Cell–laden Hydrogel Microspheres with Core–shell Scaffold Mimicking Microenvironment of Tumor

Massive fabrication of functional hepatic cancer spheroids by micropatterned GelMA hydrogel chip for drug screening

Reproducible 3D culture of multicellular tumor spheroids in supramolecular hydrogel from cancer stem cells sorted by sedimentation field-flow fractionation

Supramolecular Nanofibrillar Thermoreversible Hydrogel for Growth and Release of Cancer Spheroids.

Growth of MCF-7 Breast Cancer Cells and Efficacy of Anti-Angiogenic Agents in a Hydroxyethyl Chitosan/glycidyl Methacrylate Hydrogel

Study on Development of Composite Hydrogels With Tunable Structures and Properties for Tumor-on-a-Chip Research

A Facile and Scalable Hydrogel Patterning Method for Microfluidic 3D Cell Culture and Spheroid-in-Gel Culture Array

Generation of Multicellular Tumor Spheroids with Microwell-Based Agarose Scaffolds for Drug Testing